involucrin and Squamous-Cell-Carcinoma-of-Head-and-Neck

involucrin has been researched along with Squamous-Cell-Carcinoma-of-Head-and-Neck* in 2 studies

Other Studies

2 other study(ies) available for involucrin and Squamous-Cell-Carcinoma-of-Head-and-Neck

ArticleYear
Combined loss of expression of involucrin and cytokeratin 13 is associated with poor prognosis in squamous cell carcinoma of mobile tongue.
    Head & neck, 2021, Volume: 43, Issue:11

    This study aimed to evaluate the prognostic significance of expression levels of involucrin (IVL), cytokeratin (CK)-10 and -13 at different intratumor sites (tumor center and invading area) of oral tongue squamous cell carcinoma (OTSCC).. IVL, CK13 and CK10 expression levels were examined in a multicenter cohort of 146 OTSCCs using immunohistochemistry. External mRNA datasets were used for expression analysis and/or to validate survival associations.. External transcriptomic datasets showed downregulation of IVL and KRT13 in oral malignancies including OTSCC as compared to normal controls. The combined loss of IVL and CK13 expression at the invading core but not at the center core was significantly associated with poor differentiation and reduced 5-year overall survival. Multivariate Cox analysis confirmed the loss of CK13 and IVL expression to be an independent prognostic factor. Transcriptomic dataset corroborated immunohistochemistry results.. Combined expression levlels of IVL and CK13 might be useful as prognostic biomarkers in OTSCC.

    Topics: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Keratin-13; Prognosis; Protein Precursors; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms

2021
Epithelial oral mucosal cells: Do they behave differently when exposed to oral carcinogens?
    Cytopathology : official journal of the British Society for Clinical Cytology, 2018, Volume: 29, Issue:1

    To assess the level of maturation and proliferation of epithelial cells and the correlation with immunocytochemical expression of adhesion (E-cadherin) and cell differentiation (involucrin) markers.. Cytopathological samples were obtained from four groups of patients: control (CG, n=30); alcohol/tobacco (ATG, n=31), leucoplakia (LG, n=31), and squamous cell carcinoma (SCCG, n=22). Cytopathological smears were collected from all groups for AgNOR, Papanicolaou and immunocytochemical staining.. There was an increase in anucleated cells in ATG compared to CG and in LG compared to lesion-free groups (P<.05). In addition, there was a higher rate of intermediate cells in lesion-free groups than in LG (P=.001). When these findings were correlated with positive E-cadherin expression, there was a smaller number of anucleated and intermediate cells (P<.05). The proliferation rate was higher in the SCCG than in the CG (P<.05) and in the ATG compared to LG (P<.05). Moreover, cell proliferation increased in the presence of positive E-cadherin expression in the ATG and LG. No statistically significant results were obtained for involucrin analysis.. Cytopathology combined with quantitative techniques such as Papanicolaou, AgNOR, and immunocytochemical expression of E-cadherin detects changes associated with oral carcinogenesis. The innovative approach used in this study allows assessing the expression of cell adhesion (E-cadherin) and differentiation (involucrin) markers by means of oral mucosal cytopathology. The E-cadherin imunocytochemical expression indicated changes associated with the oral carcinogenesis process. An increase in cell proliferation rate in oral squamous cell carcinoma group was associated with the lower immunoexpression of E-cadherin. Cytopathology combined with quantitative techniques and immunocytochemical expression of E-cadherin may detect early alterations associated with oral carcinogenesis.

    Topics: Antigens, CD; Cadherins; Carcinogenesis; Carcinogens; Cell Proliferation; Female; Humans; Leukoplakia, Oral; Male; Mouth Neoplasms; Precancerous Conditions; Protein Precursors; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured

2018